CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6,049 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04442165
NCT04442165N/ACompleted

Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique Using Population-based (Sero)Surveillance

Institute of Tropical Medicine, Belgium·observational·Posted Jun 22, 2020·Updated Mar 6, 2025

In Brief

An observational study for COVID-19. Completed, enrolled 6,049 participants across 1 site.

Detailed Summary

A population-based COVID19 surveillance in a household cohort will be set-up using an existing Household demographic surveillance system (HDSS). From any individual in this population with any respiratory symptom or loss of smell or taste, with or without fever, investigators will collect a respiratory specimen and test these for SARS-CoV-2 virus, during 12 months. Demographic, epidemiological and clinical data of possible cases and of the source population will be recorded at baseline. An age-stratified serial sero-survey will be conducted at baseline in a subset of the population in the population-based COVID19 surveillance, and at 3, 6 and 12 months, after confirmation of community transmission.

Study Details

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 22, 2020
Enrollment StartDec 15, 2020
Primary CompletionMar 29, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.0 years ago